maha

Logo

November 13, 2026

Medicaid Work Requirements On Hold For Six Months As states struggle to implement a new Medicaid policy so quickly and fears of millions losing coverage, the Trump administration is giving states an optional 6-month grace period for enforcing new work requirements due on Jan. 1. The Centers for Medicare & Medicaid Services (CMS) announced the move Friday, which runs through June 30, 2027. It says this gives states a transition period to further modernize systems, improve processes, and streamline the applicant and beneficiary experience. Studies estimate that between 5 million and 10 million people could lose coverage, most due to bureaucratic snafus or a lack of paperwork awareness — not because they are not working or do not qualify for an exemption. States that implement the hold harmless period will assess whether individuals meet the work requirement or are excluded from it, but they will not deny applications or disenroll

Read More »
Logo

November 12, 2026

Could States Further Cut Back Medicaid? A new Health Affairs Forefront blog reports that nearly two-thirds of respondents in a Cornell Health Policy Insight Panel survey said the One Big Beautiful Bill Act (OBBBA) could cause states to scale back Medicaid expansions. A majority said the law’s limits on state directed payments could reduce access to care. The OBBBA could be a triple whammy – reduced enrollment for work requirements, major cutbacks in eligibility and benefits due to reduced state Medicaid match from provider taxes, and less support for providers via state directed payments. #medicaid #obbba #coverage https://www.healthaffairs.org/content/forefront/experts-states-could-curtail-aca-medicaid-expansions-response-hr-1 No Surprises Act Cripples Employers Researchers at the Employee Benefit Research Institute find that the No Surprises Act’s independent dispute resolution (IDR) process cost employer plans $8.39 billion in 2025. Additional costs equal about 63 cents per $100 spent by employer-based insurance plans. The total includes $4.73 billion in costs incurred in

Read More »
Logo

November 11, 2026

Medicare At 50? A new Senate bill would expand Medicare’s population. Under the bill, people aged 50-64 could buy into Medicare. The buy-in would be optional. Beneficiaries would be entitled to the same benefits, including access to Medicare Advantage (MA). Safeguards to stop offloading Medicaid recipients would exist. #medicare #coverage https://www.beckerspayer.com/policy-updates/democrats-renew-push-to-open-medicare-to-people-50-and-older Payers Positive in Q3, Hospitals Mixed Payers’ largely increased annual guidance during Q3 due to recovering finances, but for-profit hospitals were mixed. Tenet was a standout for performance. #healthplans #hospitals #margins https://www.beckerspayer.com/financial/payers-regain-footing-in-q3-as-for-profit-health-system-margins-slip KFF Outlook For Exchange Open Enrollment Healthcare policy group KFF outlines what to expect in Exchange open enrollment: #exchanges https://www.kff.org/affordable-care-act/9-things-to-watch-for-the-2027-aca-open-enrollment-period/ KFF Outlines 340B Medicare Change Healthcare policy group KFF covers the finalization of reduced drug payments to 340B qualified providers in Medicare. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered

Read More »
Logo

November 10, 2026

Employees To Shoulder More On Healthcare A new WTW survey finds that U.S. employers expect employees to shoulder more in terms of healthcare costs over the next two years due to projected steep annual increases. Employers anticipate costs to rise 11.1% in 2027 before plan changes and 9.7% after changes. Most employers (85%) are planning or considering shifting the cost to employees through premium contributions by 2028, compared to the 44% doing so today. Employers are also considering eliminating some generous coverage options (41%) and restricting eligibility (22%). #employercoverage #healthcare #coverage https://www.healthcaredive.com/news/workers-will-likely-have-to-shoulder-more-of-their-healthcare-costs/874257 Payers Continue Progress in Q3 By and large, payers reported positive recovery news in Q3 2026. Almost all big payers reported advancing revenue and profits in Q3. Medicaid payers reported some positive news in terms of rate hike from states. #healthplans #margins https://www.fiercehealthcare.com/payers/positive-medicaid-signals-open-enrollment-trends-recapping-major-payers-q3-results Kaiser Reports Positive Q3 News Kaiser Permanente reported 9% growth in operating revenues in Q3

Read More »
Logo

November 9, 2026

More Stars Lawsuits – We Now Have 15 In 2 Years Elevance Health and Blue Cross Blue Shield Rhode Island (BCBS RI) are the latest insurers to sue the federal government over their Medicare Advantage (MA) Star Year (SY) 2027 ratings. Others include Trinity Health, Banner Health, Verda Healthcare, and Jefferson Health. That brings the 2027 suits to 11, with 4 for SY 2026. Elevance filed suit over its SY 2026 ratings as well. The company sued the Centers for Medicare & Medicaid Services (CMS) in District of Columbia federal court on Friday. It again argues CMS violated the Administrative Procedure Act in using 11 measures that it says were adopted unlawfully. Two of these relied on Part D claims data outside the data sources allowed. If those measures were excluded, it would increase the ratings for 12 of its MA contracts and generate $516 million in additional quality bonus

Read More »
Logo

November 6, 2026

Permanent Medicare Drug Price Negotiations A new Centers for Medicare and Medicaid Services’ (CMS) regulation will set a permanent process and framework for Medicare drug price negotiations under the Inflation Reduction Act (IRA). This will ensure the program continues beyond 2029. The rule codifies and expands policies previously established through guidance for the initial 2026-28 period. For the 2029 round, by Feb. 1 CMS will select up to 20 drugs covered under Medicare Part B or Part D for price negotiations, with the potential to also select medicines included in previous rounds for renegotiation. I have championed the Trump administration’s efforts on drug prices across the board. This is yet another signal that Trump is serious. You would not have guessed that a Biden-era reform would have been so thoroughly endorsed. #drugpricing #trump #medicare https://www.fiercepharma.com/pharma/cms-makes-it-official-codifying-medicare-drug-price-negotiations-rolled-out-under-ira Humana Q3 Financials   Humana beat The Street for both earnings and revenue in Q3

Read More »
Logo

November 5, 2026

More Q3 Health Plan Financials Humana raised its 2026 guidance after reporting better than expected Q3 financial news. The Medicare Advantage (MA)-dominant insurer has reduced its footprint and benefits in an effort to get back to profitability. In 2027, it will shed more markets, products, and benefits, impacting the current plan coverage of up to 600,000 people. Clover Health is continuing to see strong results in MA, with membership growing 49% year-over-year in Q3 to approximately 157,000 members. The company posted $130 million in profit, up 77% year-over-year, and total revenue of $759 million, up 53% year-over-year. Exchange-focused Oscar Health is bucking the Exchange marketplace trends and brought in $5.1 billion in Q3 revenue, up “roughly 70%” year-over-year. In other news, a federal court has granted a preliminary injunction setting aside the Trump administration’s moratorium on new broker enrollments for the Exchange marketplace. Additional articles: https://www.modernhealthcare.com/insurance/mh-humana-2026-profit-forecast-raised-q3-earnings/ and https://www.fiercehealthcare.com/payers/nabip-sues-cms-over-moratorium-new-aca-broker-registrations and https://www.modernhealthcare.com/insurance/mh-cms-aca-exchange-brokers-court/

Read More »
Logo

November 4, 2026

Dems Have Big Healthcare Plans After Democrats took over both the House and Senate with sizeable majorities, they are looking to 2027 for major healthcare changes. Just how effective they will be is in question, though, as they lack veto-proof majorities and will be below the 60-vote filibuster threshold in the Senate. Democrats still are promising major changes. Oregon Senator Ron Wyden, set to lead the Senate Finance Committee, pledged to target insurers and drugmakers for accountability. Expanding Medicare drug price negotiations and Medicare for All could be on the docket. Medicaid and Exchange cuts will be rolled back. AI in healthcare could also be regulated. Affordability as well as the high cost of healthcare played big rolls in the Dems’ victories. On the administration side, executive orders and regulations will be how Trump will push his healthcare agenda. Stay tuned for my assessment of results tomorrow and a deep

Read More »
Logo

November 3, 2026

Part D Premiums To Surge Kaiser Health News is covering healthcare policy group KFF’s analysis that finds that standalone Part D premiums will surge up to 50% on average in 2027. It is a huge irony as President Donald Trump takes credit for major initiatives to reduce the cost of drugs. The article notes that many enrollees will likely avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during open enrollment. Those in Medicare Advantage Part D (MA-PD) plans will see less of an increase, just $2 to about $9 on average. The other big hike is in the average deductible. That will go up to $643 for PDPs from $540 in 2026. The hike in the average deductible will be $489 for MA-PDs, up from $360 in 2026. Benefits have also eroded more generally. Nearly 25 million people are enrolled in

Read More »
Logo

November 2, 2026

Wakely Explores CHOICE Actuarial consulting firm Wakely has a great white paper on the potential growth opportunities of the CHOICE coverage, once known as individual coverage health reimbursement accounts (ICHRAs), which afford employers the ability to subsidize employees’ purchase of coverage in the individual market. The report describes how CHOICE works, current size and momentum, barriers to adoption, how large group and state employee health plans could expand the potential CHOICE opportunity, and more. It notes that the relative affordability of individual coverage compared with small group coverage is a central driver of employer adoption. At the same time, some of the largest growth has been seen with larger employers. #choice #ichras #coverage #exchanges https://www.wakely.com/blog/could-choice-reshape-the-individual-aca-market/ States Filling Subsidy Void A number of states, including Rhode Island, Virginia, California, Connecticut, and New Mexico are launching or expanding Exchange subsidy programs ahead of 2027 open enrollment. New Mexico is the only state

Read More »

Available Now

$30.00